Keywords: Geron, Human embyonic stem cell-based therapy, GRNOPC1

Geron initiates clinical trial of human embryonic stem cell-based therapy

Article | 13 October 2010

Print This

Less than two months after the US government lifted its clinical hold on such research, Geron Corp (Nasdaq: GERN) has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in